Global Transdermal Patches Market by Product (Matrix, Multi-layer Drug-in-Adhesive, Reservoir), Type (Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch), Technology, Application, Distribution Channel, End Users - Forecast 2023-2030- Product Image

Sale

Global Transdermal Patches Market by Product (Matrix, Multi-layer Drug-in-Adhesive, Reservoir), Type (Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch), Technology, Application, Distribution Channel, End Users - Forecast 2023-2030

Report
188 Pages
March 2024
Region: Global
360iResearch™
ID: 5519528

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Transdermal Patches Market size was estimated at USD 7.46 billion in 2022, USD 8.57 billion in 2023, and is expected to grow at a CAGR of 16.21% to reach USD 24.84 billion by 2030.

Transdermal patches offer a novel therapeutic approach to managing chronic conditions by delivering medication directly through the skin into the bloodstream. These patches are used for a range of purposes, including nicotine cessation, hormone replacement therapy, pain management, and the administration of anti-hypertensive, anti-inflammatory, and contraceptive medications. The growing aging population facing difficulty in oral medication administration may benefit from the ease of use of transdermal patches. The prevalence of chronic diseases and the rising preference for non-invasive drug delivery methods are raising the need for transdermal patches. However, high costs and limitations associated with transdermal patches can impede end-user adoption. Moreover, ongoing R&D to develop innovative drug delivery systems and enhance the effectiveness and range of available transdermal drug delivery systems are expected to encourage their use to treat chronic conditions globally.

Regional Insights

The transdermal patches market is developing in the Americas owing to the advanced healthcare infrastructure, high healthcare expenditure, increasing prevalence of chronic diseases, and the presence of key market players actively involved in developing new transdermal technologies. Favorable regulatory policies and a strong focus on research and development activities contribute to the transdermal patch market's growth in the Americas. Europe is another crucial market for transdermal patches owing to the increasing geriatric population with chronic conditions requiring convenient medication delivery options such as transdermal patches. Governments and healthcare organizations across Europe have been advocating for cost-effective treatment methods consistent with an at-home healthcare trend, significantly driving the need for self-administered therapies such as transdermal patches. Health infrastructure and economic developments are improving the accessibility and adoption of transdermal patches by end-users in the Middle East and Africa region. The Asia-Pacific region is emerging as the fastest-growing market for transdermal patches due to increasing healthcare awareness and the growing need for chronic disease management. Improvements in healthcare infrastructure and rising income levels are forecasted to support the growth of the transdermal patches market in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transdermal Patches Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transdermal Patches Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdhexPharma SAS, ALVOGEN, Amneal Pharmaceuticals, Inc., Bayer AG, BioNxt Solutions Inc., Bliss GVS Pharma Ltd., Boehringer Ingelheim International GmbH, Corium, Inc., Corsair Pharma, Inc., DifGen Pharmaceuticals LLC, Endo International plc, Gedeon Richter Plc, GlaxoSmithKline Plc, Icure Pharmaceutical Inc., Johnson & Johnson Services, Inc., LAVIPHARM GROUP HOLDING S.A., Luye Pharma Group Ltd, Medherant Limited, Nitto Denko Corporation, Novartis AG, Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc., Nutriband Inc, Perrigo Company plc, ProSolus, Inc., Purdue Pharma L.P., Sparsha Pharma International Pvt Ltd, Tapemark by LTS Lohmann Therapie-Systeme AG, Teikoku Seiyaku Co., Ltd., Tesa SE by Beiersdorf AG, Teva Pharmaceutical Industries Ltd., UCB S.A., Viatris Inc., and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Transdermal Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Matrix
- Multi-layer Drug-in-Adhesive
- Reservoir
- Single-layer Drug-in-Adhesive
Type
- Buprenorphine Transdermal Patch
- Clonidine Transdermal Patch
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Oxybutynin Transdermal Patch
Technology
- Chemical Enhancers
- Electric Current
- Mechanical Arrays
- Thermal Ablation
Application
- Hormonal Therapy
- Overactive Bladder
- Pain Relief
- Smoking Reduction & Cessation Aid
Distribution Channel
- Offline
- Online
End Users
- Clinics
- Home Care Settings
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Transdermal Patches Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transdermal Patches Market?
What are the technology trends and regulatory frameworks in the Transdermal Patches Market?
What is the market share of the leading vendors in the Transdermal Patches Market?
Which modes and strategic moves are suitable for entering the Transdermal Patches Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Transdermal Patches Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased use of transdermal patches to treat chronic conditions worldwide
5.1.1.2. Rising preference for controlled drug release and non-invasive drug delivery solutions
5.1.1.3. Growing number of government approvals for transdermal patches
5.1.2. Restraints
5.1.2.1. High costs associated with transdermal patches
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
5.1.3.2. Emerging advances in the formulation and manufacturing of transdermal patches
5.1.4. Challenges
5.1.4.1. Limitations associated with transdermal drugs along with product recalls
5.2. Market Segmentation Analysis
5.2.1. Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
5.2.2. Type: Extensive requirement for nicotine transdermal patches
5.2.3. Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
5.2.4. Application: Expanding use of transdermal patches for hormonal therapy
5.2.5. Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
5.2.6. End Users: Increasing prescription of transdermal patches in hospitals
5.3. Market Trend Analysis
5.3.1. Supportive government approval landscape for transdermal patches in the Americas
5.3.2. Growing prevalence of chronic pain and diabetes propelling the growth of transdermal patches in the APAC region
5.3.3. Improving healthcare infrastructure to increase access of innovative transdermal patches in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Transdermal Patches Market, by Product

6.1. Introduction
6.2. Matrix
6.3. Multi-layer Drug-in-Adhesive
6.4. Reservoir
6.5. Single-layer Drug-in-Adhesive

7. Transdermal Patches Market, by Type

7.1. Introduction
7.2. Buprenorphine Transdermal Patch
7.3. Clonidine Transdermal Patch
7.4. Fentanyl Transdermal Patch
7.5. Nicotine Transdermal Patch
7.6. Oxybutynin Transdermal Patch

8. Transdermal Patches Market, by Technology

8.1. Introduction
8.2. Chemical Enhancers
8.3. Electric Current
8.4. Mechanical Arrays
8.5. Thermal Ablation

9. Transdermal Patches Market, by Application

9.1. Introduction
9.2. Hormonal Therapy
9.3. Overactive Bladder
9.4. Pain Relief
9.5. Smoking Reduction & Cessation Aid

10. Transdermal Patches Market, by Distribution Channel

10.1. Introduction
10.2. Offline
10.3. Online

11. Transdermal Patches Market, by End Users

11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals

12. Americas Transdermal Patches Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Transdermal Patches Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Transdermal Patches Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
15.3.1. Merger & Acquisition
15.3.1.1. Almirall Acquires Rights To Distribute Alzheimer’s Treatment In Spain For An Initial EUR 45 Million
15.3.1.2. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
15.3.1.3. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma’s Growth Path
15.3.2. Agreement, Collaboration, & Partnership
15.3.2.1. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
15.3.2.2. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson’s Disease
15.3.3. New Product Launch & Enhancement
15.3.3.1. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
15.3.3.2. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
15.3.4. Investment & Funding
15.3.4.1. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
15.3.4.2. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
15.3.4.3. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
15.3.5. Award, Recognition, & Expansion
15.3.5.1. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
15.3.5.2. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson’s Disease

16. Competitive Portfolio

16.1. Key Company Profiles
16.1.1. AbbVie Inc.
16.1.2. AdhexPharma SAS
16.1.3. ALVOGEN
16.1.4. Amneal Pharmaceuticals, Inc.
16.1.5. Bayer AG
16.1.6. BioNxt Solutions Inc.
16.1.7. Bliss GVS Pharma Ltd.
16.1.8. Boehringer Ingelheim International GmbH
16.1.9. Corium, Inc.
16.1.10. Corsair Pharma, Inc.
16.1.11. DifGen Pharmaceuticals LLC
16.1.12. Endo International plc
16.1.13. Gedeon Richter Plc
16.1.14. GlaxoSmithKline Plc
16.1.15. Icure Pharmaceutical Inc.
16.1.16. Johnson & Johnson Services, Inc.
16.1.17. LAVIPHARM GROUP HOLDING S.A.
16.1.18. Luye Pharma Group Ltd
16.1.19. Medherant Limited
16.1.20. Nitto Denko Corporation
16.1.21. Novartis AG
16.1.22. Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
16.1.23. Nutriband Inc
16.1.24. Perrigo Company plc
16.1.25. ProSolus, Inc.
16.1.26. Purdue Pharma L.P.
16.1.27. Sparsha Pharma International Pvt Ltd
16.1.28. Tapemark by LTS Lohmann Therapie-Systeme AG
16.1.29. Teikoku Seiyaku Co., Ltd.
16.1.30. Tesa SE by Beiersdorf AG
16.1.31. Teva Pharmaceutical Industries Ltd.
16.1.32. UCB S.A.
16.1.33. Viatris Inc.
16.1.34. Zydus Group
16.2. Key Product Portfolio

17. Appendix

17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
FIGURE 2. TRANSDERMAL PATCHES MARKET SIZE, 2022 VS 2030
FIGURE 3. TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
FIGURE 7. TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 12. TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 16. TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2022 VS 2030 (%)
FIGURE 18. TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 22. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 27. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 28. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 11. TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 17. TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 30. TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 52. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 84. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 90. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 102. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 138. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 163. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 169. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 175. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 181. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 193. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. ITALY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 211. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. NORWAY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 217. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. POLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 223. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. QATAR TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SPAIN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 265. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. TURKEY TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 283. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 284. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 285. TRANSDERMAL PATCHES MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
AdhexPharma SAS
ALVOGEN
Amneal Pharmaceuticals, Inc.
Bayer AG
BioNxt Solutions Inc.
Bliss GVS Pharma Ltd.
Boehringer Ingelheim International GmbH
Corium, Inc.
Corsair Pharma, Inc.
DifGen Pharmaceuticals LLC
Endo International plc
Gedeon Richter Plc
GlaxoSmithKline Plc
Icure Pharmaceutical Inc.
Johnson & Johnson Services, Inc.
LAVIPHARM GROUP HOLDING S.A.
Luye Pharma Group Ltd
Medherant Limited
Nitto Denko Corporation
Novartis AG
Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
Nutriband Inc
Perrigo Company plc
ProSolus, Inc.
Purdue Pharma L.P.
Sparsha Pharma International Pvt Ltd
Tapemark by LTS Lohmann Therapie-Systeme AG
Teikoku Seiyaku Co., Ltd.
Tesa SE by Beiersdorf AG
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Viatris Inc.
Zydus Group

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 8.57 Billion
Forecasted Market Value ( USD ) by 2030	$ 24.84 Billion
Compound Annual Growth Rate	16.2%
Regions Covered	Global
No. of Companies Mentioned	34

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Forecast 2023-2030

Global Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End-user, and Region - Forecast to 2029

Global Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type (Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Others), By Patch Type, By Regional Outlook and Forecast, 2023 - 2030

Global Transdermal Patches Market: Focus on Distribution Channel, Application, End User, Patch Type, Adhesive Type, and Over 16 Countries' Data - Analysis and Forecast, 2023-2033

Transdermal Skin Patches Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028